sear vpdupdate week44 2017
VPD Update for Week 44, 2017
Data as of 30 October 2017
Immunization and Vaccine
Development (IVD) SEARO
Protecting People from Vaccine
Preventable Diseases
Last wild poliovirus cases confirmed by type, SEAR
WPV Type 2
District: Aligarh
State: Uttar Pradesh (India)
Date of onset: 24-Oct-1999
WPV Type 3
District: Pakur
State: Jharkhand (India)
Date of onset: 22-Oct-2010
WPV Type 1
District: Howrah
State: West Bengal (India)
Date of onset: 13-Jan-2011
*Dots are randomly placed within blocks (Sub-districts)
Last wild poliovirus
case by country
Country
Year
Bangladesh
2006
Bhutan
1986
DPR Korea
1996
India
2011
Indonesia
2006
Maldives
1994
Myanmar
2007
Nepal
2010
Sri Lanka
1993
Thailand
1997
Timor-Leste
1995
Data as of 06 November 2017
Monthly Distribution of AFP Cases
SEAR, 2016 – 2017
2016
total
AFP
2017
AFP to
date
Sep-16
Oct-16
Nov-16
Dec-16
Jan-17
Feb-17
Mar-17
Apr-17
May-17
Jun-17
Jul-17
Aug-17
Sep-17
Oct-17
AFP cases by month of paralysis onset, last 14 months (data from weekly case-based reports)
Date of last
report
1 437
1 216
122
100
99
65
114
119
135
147
125
96
153
108
111
108
06-Nov-17
Bhutan
11
7
1
0
2
1
0
0
1
2
0
0
1
0
3
0
06-Nov-17
DPR Korea
105
79
7
5
4
0
14
10
8
13
7
13
3
11
0
0
29-Sep-17
Country
Bangladesh
India
46 500 32 010 4 581 3 675 3 364 3 230 3 155 2 752 2 873 2 764 3 078 3 169 4 000 4 742 3 664 1 813 03-Nov-17
Indonesia
1 409
1 018
0
0
0
0
102
110
111
102
109
72
106
130
115
61
06-Nov-17
Maldives
2
4
0
0
0
0
0
0
1
2
0
0
1
0
0
0
31-Oct-17
Myanmar
466
300
51
54
33
29
18
24
14
18
24
28
52
64
39
19
02-Nov-17
Nepal
455
294
48
37
19
20
34
27
34
31
33
22
34
43
21
15
05-Nov-17
Sri Lanka
65
60
3
7
3
6
7
13
6
4
6
4
1
6
3
10
02-Nov-17
Thailand
246
158
30
24
20
16
30
19
16
6
10
15
21
26
13
2
30-Oct-17
Timor-Leste
10
1
0
4
1
0
0
0
0
0
0
0
0
1
0
0
27-Sep-17
TOTAL
50 706 35 147 4 843 3 906 3 545 3 367 3 474 3 074 3 199 3 089 3 392 3 419 4 372 5 131 3 969 2 028
Data as of 06 November 2017
Primary Culture Results from AFP Cases, 2016
Bangladesh
IPH, Dhaka
Bhutan
NIH, Bangkok
DPRK
India
NPL, Pyongyang
Pending1
NPEV
Only
Negative
1 433
8
0
348
1 077
0
10
1
0
0
9
0
Results
Received
by lab
% Primary Culture
Reports Within 14
days
0
2 863
98.4
21.3
64
2
0
0
0
20
100
0
0
0
0
0
0
14 days
Number
received by
lab
Wild
Positive
Culture
Positive
Culture +
NPEV
91
0
0
14
77
0
0
194
93
14.4
0
0
0
BJMC, Ahmedabad
6 098
233
26
1 127
4 712
0
0
12 173
99.9
14.8
20
2
0
0
NIV, Bengaluru
4 395
190
35
1 200
2 970
0
0
8 791
97.4
22.9
0
0
0
0
IoS, Kolkatta
7 146
91
21
1 011
6 023
0
0
14 287
98.4
11.0
5
0
0
0
KIPM, Chennai
5 122
89
9
954
4 070
0
0
10 232
99.8
14.9
0
0
0
0
NCDC, Delhi
6 934
212
20
885
5 817
0
0
13 830
99.6
10.8
10
0
0
0
CRI, Kasauli
2 066
35
0
276
1 755
0
0
4 142
99.9
11.5
0
0
0
0
SGPGI, Lucknow
8 811
281
29
1 551
6 950
0
0
17 602
89.7
13.5
0
0
0
0
0
ERC, Mumbai
4 940
158
14
1 187
3 581
0
0
9 974
97.4
21.0
45
4
0
45 512
1 289
154
8 191
35 878
0
0
91 031
97.1
14.7
80
6
0
0
Bio Farma, Bandung
440
13
0
40
387
0
0
871
95
7.9
0
0
0
0
NIHRD, Jakarta
513
14
2
45
452
0
0
1 016
98
7.3
0
0
0
0
India Sub Total
Indonesia
Number of AFP
cases with
specimens received
in Lab
VDPV
Polio Laboratories
Vaccine
Country
Specimens from other sources2
AFP specimens
% NPEV
AFP cases
PHL, Surabaya
Indonesia Sub Total
402
14
0
27
361
0
0
799
100
5.4
0
0
0
0
1 355
41
2
112
1 200
0
0
2 686
97.5
6.9
0
0
0
0
Maldives
MRI, Colombo
2
0
0
0
2
0
0
4
100
0
0
0
0
0
Myanmar
NHL, Yangon
466
5
2
63
396
0
0
931
96
11.7
0
0
0
0
NIH, Bangkok
449
4
2
103
340
0
0
898
100
20.1
67
3
0
0
Labs in India3
3
0
0
0
3
0
0
6
0
0.0
0
0
0
0
Sri Lanka
MRI, Colombo
53
1
0
3
49
0
0
104
81
3.8
266
6
0
0
Thailand
NIH, Bangkok
235
4
0
25
206
0
0
468
100.0
8.3
0
0
0
0
Timor-Leste
NIH, Bangkok
1 353
160
8 859
39 237
0
0
99 205
97.2
14.6
477
17
0
0
Nepal
SEAR
0
49 609
1
Calculation based on date specimen received in laboratory subtracted from date result report to the national programme.
2
Stool samples collected from contact and healthy children survey.
3
Stool samples from cross notified AFP cases tested in India
Data as of 06 November 2017
Primary Culture Results from AFP Cases, 2017
IPH, Dhaka
NIH, Bangkok
DPRK
India
NPL, Pyongyang
Positive
Culture
NPEV
Only
Negative
1 209
17
1
267
853
27
4
0
0
1
3
0
Results
Received
by lab
% Primary Culture
Reports Within 14
days
44
2 413
89.6
19.8
79
1
0
0
0
8
100
25
0
0
0
0
0
14 days
Number
received by
lab
75
0
0
14
61
0
0
152
93.2
18.4
0
0
0
BJMC, Ahmedabad
4 450
191
27
945
3 169
118
0
8 882
95.1
18.0
10
0
0
0
NIV, Bengaluru
2 885
119
23
769
1 888
76
10
5 763
97.2
23.0
5
0
0
0
IoS, Kolkatta
4 697
152
17
1 099
3 428
1
0
9 367
84.5
18.9
0
0
0
0
KIPM, Chennai
2 651
43
7
534
2 065
2
0
5 229
99.1
16.5
0
0
0
0
NCDC, Delhi
4 877
181
22
740
3 751
183
0
9 732
97.3
13.5
5
0
0
0
CRI, Kasauli
1 595
17
2
253
1 305
18
0
3 196
97.7
12.8
0
0
0
0
SGPGI, Lucknow
7 575
250
35
1 799
5 280
211
0
15 130
90.1
19.4
5
0
0
0
ERC, Mumbai
2 051
124
12
354
1 556
5
0
4 074
92.4
15.4
5
0
0
0
30 781
1 077
145
6 493
22 442
614
10
61 373
93.1
17.7
30
0
0
0
316
2
0
28
273
12
1
628
89
8.6
0
0
0
0
India Sub Total
Bio Farma, Bandung
Indonesia
Pending1
Positive
Culture +
NPEV
Wild
Bangladesh
Bhutan
Number of AFP
cases with
specimens
received in Lab
VDPV
Polio Laboratories
Vaccine
Country
Specimens from other sources2
AFP specimens
% NPEV
AFP cases
NIHRD, Jakarta
403
1
0
27
344
28
3
797
100
6.1
0
0
0
0
PHL, Surabaya
269
1
0
25
237
6
0
531
100
8.5
0
0
0
0
988
4
0
80
854
46
4
1 956
96.6
7.6
0
0
0
0
Indonesia Sub Total
Maldives
MRI, Colombo
2
0
0
0
2
0
0
3
100
0
0
0
0
0
Myanmar
NHL, Yangon
296
4
1
47
236
8
0
596
93
14.1
30
0
0
0
NIH, Bangkok
292
4
1
69
207
11
0
584
99
21.9
19
0
0
0
0
0
0
0
0
0
0
0
0
0.0
0
0
0
0
Nepal
3
Labs in India
Sri Lanka
MRI, Colombo
37
0
0
0
35
2
0
79
96
0.0
214
1
0
0
Thailand
NIH, Bangkok
130
4
1
10
108
0
7
262
99.2
7.3
0
0
0
0
Timor-Leste
NIH, Bangkok
0
1 110
149
6 981
24 801
708
65
67 426
93.1
17.5
372
2
0
0
SEAR
33 814
1
Calculation based on date specimen received in laboratory subtracted from date result report to the national programme.
2
Stool samples collected from contact and healthy children survey.
3
Stool samples from cross notified AFP cases tested in India
Data as of 06 November 2017
Poliovirus Detected in Sewage Samples, India, 2016
NPSP- Data as of 03 November 2017
Poliovirus Detected in Sewage Samples, India, 2017
NPSP- Data as of 03 November 2017
Laboratory Data of Environmental Surveillance 2015-2017,
NPML,IPH Bangladesh, Report: October 02,2017)
Laboratory Data of Environmental Surveillance 2015-2017, NPML,IPH Bangladesh, Report: October 02,2017)
Report on Epidemiological Week 39, 2017, NPML-IPH, Bangladesh
Site
City
# Site
Dhaka
Niketon
Gazipur Esthema
Dhaka
Gulshan
Dhaka
Bashabo
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
92 95 96
100
104
108
## ## ## ## ## ##
99
203
107
111 ## ## ## c
##
s94
98
102
106
110 ## ## ## ## ##
s93
97
101
105
109 ## ## ## ## ##
Sites: Bangladesh
Site 1= Hatirjheel-Niketon,Dhaka
Site 2= Esthema-Kamarpara,Tongi)
Site 3= Wasa Sewarage Pit-Gulshan,Dhaka
Site 4= Bashabo Sewarage pit,Dhaka
Sample collected fortnightly
22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 #
## ## ## ## ## ## ## ## ##
134 ## ## ## ## ## ## ## ##
133 ## ## ## ## ## ## ## ##
135 ## ## ##
## ## ## ## ##
Summary : : Total site 4
Total sample collected 168
Total sample with result available:
163
Total sample positive for WPV(with type)
0
Total sample positive for VDPV
0
Total sample positive for SLPV3
8
Total sample positive for SLPV2
1
Total sample positive for SLPV1
3
Total sample positive for NPEV
78
Total RD Positive:
90
Total sample NVI:
73
Note: NPML-IPH lab processes: Sewage samples are tested in cell culture, virus isolation done, confirmed by realtime PCR (ITD)
Note: ERC sequencing report has confirmed the ES-158-ITD discordant sample finally as"PV SL3(vaccine) with 2 neucleotide change".
Reported by National Polio Measles and AMES(JE) Laboratory, IPH, Bangladesh
WPV1
VDPV
SLPV2
SL PV3
NPEV
Negetive (NVI)
Discordant
under process
Not collected
SLPV1
Poliovirus Detected in Sewage Samples
Indonesia - 2017
Province
DKI Jakarta
East Java
West Java
Yogyakarta
1
2
3
4
5
6
7
8
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52
Province
1
2
3
4
5
6
7
8
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53
1
2
3
4
5
6
7
8
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52
Thailand -2016
Bangkok
Samut Sakhon
Thailand- 2017
Province
Bangkok
Samut Sakhon
Type 1 Sabin
Type 1 VDPV
Wild polio type 1
Negative for Polio and NPEV
Type 2 Sabin
Type 2 VDPV
Wild polio type 3
Result pending
Type 3 Sabin
Type 3 VDPV
NPEV
Sampling not scheduled
Type 1 Sabin + 3 Sabin
Data as of 06 November 2017
Measles and Rubella Serology (IgM) , 2017
Results
Country
Laboratories
Bangladesh
Dhaka
Bhutan
Thimphu
DPR Korea
India
%
#
%
5592
2395
42.8
188
5.9
64.1
388
388
59
15.2
7
2.1
92.0
67
61
0
0.0
0
0.0
100.0
434
299
68.9
30
22.2
100.0
Bengaluru
688
623
143
23.0
169
35.2
91.5
Bhopal
158
158
111
70.3
4
8.5
99.4
Chandigarh
118
118
38
32.2
11
13.8
100.0
Chennai
832
163
49
30.1
54
47.4
99.4
Delhi
132
132
83
62.9
6
12.2
97.0
Guw ahati
272
153
103
67.3
14
28.0
100.0
80
80
32
40.0
7
14.6
100.0
Jaipur
308
308
208
67.5
7
7.0
79.9
Kolkata
812
812
318
39.2
302
61.1
86.6
1509
1313
763
58.1
84
15.3
84.3
384
384
101
26.3
119
42.0
77.9
Pune
619
462
264
57.1
45
22.7
90.7
6346
5140
2512
48.9
852
32.4
89.0
Bandung
1094
1094
569
52.0
158
30.1
92.7
Jakarta
4407
3263
899
27.6
1012
42.8
29.5
Surabaya
3349
2357
1235
52.4
327
29.1
47.5
India Total
Yogyakarta
Indonesia Total
Maldives
Male
Myanm ar
Yangon
Nepal
Kathmandu
3527
3527
983
27.9
1125
44.2
77.1
12377
10241
3686
36.0
2622
40.0
56.8
87.9
58
58
1
1.7
1
1.8
1493
1483
991
66.8
5
1.0
99.0
709
709
56
7.9
16
2.5
90.4
Colombo
138
137
5
3.6
8
6.1
86.1
Bangkok
548
548
286
52.2
2
0.8
100.0
Chiang Mai
28
28
7
25.0
0
0.0
100.0
Chiang Rai
29
29
7
24.1
0
0.0
86.2
Chon Buri
223
142
48
33.8
1
1.1
100.0
52
52
10
19.2
1
2.4
100.0
7
7
3
42.9
0
0.0
100.0
61
61
27
44.3
2
5.9
100.0
100.0
Khon Kaen
Nakhon Saw an
Nakhonratchasima
Phitsanulok
52
52
15
28.8
2
5.4
Samut Songkhram
383
383
240
62.7
4
2.8
97.9
Songkhla
776
776
631
81.3
3
2.1
100.0
Surat Thani
6
6
0
0.0
0
0.0
100.0
Trang
54
54
10
18.5
8
18.2
100.0
Ubon Ratchathani
54
54
9
16.7
1
2.2
100.0
Udon Thani
11
11
4
36.4
0
0.0
100.0
2284
2203
1297
58.9
24
2.6
99.5
80
80
0
0.0
3
3.8
87.5
29532
26092
11002
42.2
3726
24.7
72.6
Thailand Total
Tim or-Leste
% Measles Results
Reported w ithin 4 Days
Rubella +ve
434
Patna
Thailand
#
5592
Measles +ve
Pyongyang
Lucknow
Sri Lanka
Num ber Tested
Ahmedabad
Hyderabad
Indonesia
Num ber of Serum
Sam ples Received
Dili
TOTAL
Source: Reported by SEAR Measles Laboratory Netw ork
NR=No Report
Source: Monthly Reported by SEAR Measles Laboratory Network
Data as of 30 September 2017
Data as of 30 October 2017
Immunization and Vaccine
Development (IVD) SEARO
Protecting People from Vaccine
Preventable Diseases
Last wild poliovirus cases confirmed by type, SEAR
WPV Type 2
District: Aligarh
State: Uttar Pradesh (India)
Date of onset: 24-Oct-1999
WPV Type 3
District: Pakur
State: Jharkhand (India)
Date of onset: 22-Oct-2010
WPV Type 1
District: Howrah
State: West Bengal (India)
Date of onset: 13-Jan-2011
*Dots are randomly placed within blocks (Sub-districts)
Last wild poliovirus
case by country
Country
Year
Bangladesh
2006
Bhutan
1986
DPR Korea
1996
India
2011
Indonesia
2006
Maldives
1994
Myanmar
2007
Nepal
2010
Sri Lanka
1993
Thailand
1997
Timor-Leste
1995
Data as of 06 November 2017
Monthly Distribution of AFP Cases
SEAR, 2016 – 2017
2016
total
AFP
2017
AFP to
date
Sep-16
Oct-16
Nov-16
Dec-16
Jan-17
Feb-17
Mar-17
Apr-17
May-17
Jun-17
Jul-17
Aug-17
Sep-17
Oct-17
AFP cases by month of paralysis onset, last 14 months (data from weekly case-based reports)
Date of last
report
1 437
1 216
122
100
99
65
114
119
135
147
125
96
153
108
111
108
06-Nov-17
Bhutan
11
7
1
0
2
1
0
0
1
2
0
0
1
0
3
0
06-Nov-17
DPR Korea
105
79
7
5
4
0
14
10
8
13
7
13
3
11
0
0
29-Sep-17
Country
Bangladesh
India
46 500 32 010 4 581 3 675 3 364 3 230 3 155 2 752 2 873 2 764 3 078 3 169 4 000 4 742 3 664 1 813 03-Nov-17
Indonesia
1 409
1 018
0
0
0
0
102
110
111
102
109
72
106
130
115
61
06-Nov-17
Maldives
2
4
0
0
0
0
0
0
1
2
0
0
1
0
0
0
31-Oct-17
Myanmar
466
300
51
54
33
29
18
24
14
18
24
28
52
64
39
19
02-Nov-17
Nepal
455
294
48
37
19
20
34
27
34
31
33
22
34
43
21
15
05-Nov-17
Sri Lanka
65
60
3
7
3
6
7
13
6
4
6
4
1
6
3
10
02-Nov-17
Thailand
246
158
30
24
20
16
30
19
16
6
10
15
21
26
13
2
30-Oct-17
Timor-Leste
10
1
0
4
1
0
0
0
0
0
0
0
0
1
0
0
27-Sep-17
TOTAL
50 706 35 147 4 843 3 906 3 545 3 367 3 474 3 074 3 199 3 089 3 392 3 419 4 372 5 131 3 969 2 028
Data as of 06 November 2017
Primary Culture Results from AFP Cases, 2016
Bangladesh
IPH, Dhaka
Bhutan
NIH, Bangkok
DPRK
India
NPL, Pyongyang
Pending1
NPEV
Only
Negative
1 433
8
0
348
1 077
0
10
1
0
0
9
0
Results
Received
by lab
% Primary Culture
Reports Within 14
days
0
2 863
98.4
21.3
64
2
0
0
0
20
100
0
0
0
0
0
0
14 days
Number
received by
lab
Wild
Positive
Culture
Positive
Culture +
NPEV
91
0
0
14
77
0
0
194
93
14.4
0
0
0
BJMC, Ahmedabad
6 098
233
26
1 127
4 712
0
0
12 173
99.9
14.8
20
2
0
0
NIV, Bengaluru
4 395
190
35
1 200
2 970
0
0
8 791
97.4
22.9
0
0
0
0
IoS, Kolkatta
7 146
91
21
1 011
6 023
0
0
14 287
98.4
11.0
5
0
0
0
KIPM, Chennai
5 122
89
9
954
4 070
0
0
10 232
99.8
14.9
0
0
0
0
NCDC, Delhi
6 934
212
20
885
5 817
0
0
13 830
99.6
10.8
10
0
0
0
CRI, Kasauli
2 066
35
0
276
1 755
0
0
4 142
99.9
11.5
0
0
0
0
SGPGI, Lucknow
8 811
281
29
1 551
6 950
0
0
17 602
89.7
13.5
0
0
0
0
0
ERC, Mumbai
4 940
158
14
1 187
3 581
0
0
9 974
97.4
21.0
45
4
0
45 512
1 289
154
8 191
35 878
0
0
91 031
97.1
14.7
80
6
0
0
Bio Farma, Bandung
440
13
0
40
387
0
0
871
95
7.9
0
0
0
0
NIHRD, Jakarta
513
14
2
45
452
0
0
1 016
98
7.3
0
0
0
0
India Sub Total
Indonesia
Number of AFP
cases with
specimens received
in Lab
VDPV
Polio Laboratories
Vaccine
Country
Specimens from other sources2
AFP specimens
% NPEV
AFP cases
PHL, Surabaya
Indonesia Sub Total
402
14
0
27
361
0
0
799
100
5.4
0
0
0
0
1 355
41
2
112
1 200
0
0
2 686
97.5
6.9
0
0
0
0
Maldives
MRI, Colombo
2
0
0
0
2
0
0
4
100
0
0
0
0
0
Myanmar
NHL, Yangon
466
5
2
63
396
0
0
931
96
11.7
0
0
0
0
NIH, Bangkok
449
4
2
103
340
0
0
898
100
20.1
67
3
0
0
Labs in India3
3
0
0
0
3
0
0
6
0
0.0
0
0
0
0
Sri Lanka
MRI, Colombo
53
1
0
3
49
0
0
104
81
3.8
266
6
0
0
Thailand
NIH, Bangkok
235
4
0
25
206
0
0
468
100.0
8.3
0
0
0
0
Timor-Leste
NIH, Bangkok
1 353
160
8 859
39 237
0
0
99 205
97.2
14.6
477
17
0
0
Nepal
SEAR
0
49 609
1
Calculation based on date specimen received in laboratory subtracted from date result report to the national programme.
2
Stool samples collected from contact and healthy children survey.
3
Stool samples from cross notified AFP cases tested in India
Data as of 06 November 2017
Primary Culture Results from AFP Cases, 2017
IPH, Dhaka
NIH, Bangkok
DPRK
India
NPL, Pyongyang
Positive
Culture
NPEV
Only
Negative
1 209
17
1
267
853
27
4
0
0
1
3
0
Results
Received
by lab
% Primary Culture
Reports Within 14
days
44
2 413
89.6
19.8
79
1
0
0
0
8
100
25
0
0
0
0
0
14 days
Number
received by
lab
75
0
0
14
61
0
0
152
93.2
18.4
0
0
0
BJMC, Ahmedabad
4 450
191
27
945
3 169
118
0
8 882
95.1
18.0
10
0
0
0
NIV, Bengaluru
2 885
119
23
769
1 888
76
10
5 763
97.2
23.0
5
0
0
0
IoS, Kolkatta
4 697
152
17
1 099
3 428
1
0
9 367
84.5
18.9
0
0
0
0
KIPM, Chennai
2 651
43
7
534
2 065
2
0
5 229
99.1
16.5
0
0
0
0
NCDC, Delhi
4 877
181
22
740
3 751
183
0
9 732
97.3
13.5
5
0
0
0
CRI, Kasauli
1 595
17
2
253
1 305
18
0
3 196
97.7
12.8
0
0
0
0
SGPGI, Lucknow
7 575
250
35
1 799
5 280
211
0
15 130
90.1
19.4
5
0
0
0
ERC, Mumbai
2 051
124
12
354
1 556
5
0
4 074
92.4
15.4
5
0
0
0
30 781
1 077
145
6 493
22 442
614
10
61 373
93.1
17.7
30
0
0
0
316
2
0
28
273
12
1
628
89
8.6
0
0
0
0
India Sub Total
Bio Farma, Bandung
Indonesia
Pending1
Positive
Culture +
NPEV
Wild
Bangladesh
Bhutan
Number of AFP
cases with
specimens
received in Lab
VDPV
Polio Laboratories
Vaccine
Country
Specimens from other sources2
AFP specimens
% NPEV
AFP cases
NIHRD, Jakarta
403
1
0
27
344
28
3
797
100
6.1
0
0
0
0
PHL, Surabaya
269
1
0
25
237
6
0
531
100
8.5
0
0
0
0
988
4
0
80
854
46
4
1 956
96.6
7.6
0
0
0
0
Indonesia Sub Total
Maldives
MRI, Colombo
2
0
0
0
2
0
0
3
100
0
0
0
0
0
Myanmar
NHL, Yangon
296
4
1
47
236
8
0
596
93
14.1
30
0
0
0
NIH, Bangkok
292
4
1
69
207
11
0
584
99
21.9
19
0
0
0
0
0
0
0
0
0
0
0
0
0.0
0
0
0
0
Nepal
3
Labs in India
Sri Lanka
MRI, Colombo
37
0
0
0
35
2
0
79
96
0.0
214
1
0
0
Thailand
NIH, Bangkok
130
4
1
10
108
0
7
262
99.2
7.3
0
0
0
0
Timor-Leste
NIH, Bangkok
0
1 110
149
6 981
24 801
708
65
67 426
93.1
17.5
372
2
0
0
SEAR
33 814
1
Calculation based on date specimen received in laboratory subtracted from date result report to the national programme.
2
Stool samples collected from contact and healthy children survey.
3
Stool samples from cross notified AFP cases tested in India
Data as of 06 November 2017
Poliovirus Detected in Sewage Samples, India, 2016
NPSP- Data as of 03 November 2017
Poliovirus Detected in Sewage Samples, India, 2017
NPSP- Data as of 03 November 2017
Laboratory Data of Environmental Surveillance 2015-2017,
NPML,IPH Bangladesh, Report: October 02,2017)
Laboratory Data of Environmental Surveillance 2015-2017, NPML,IPH Bangladesh, Report: October 02,2017)
Report on Epidemiological Week 39, 2017, NPML-IPH, Bangladesh
Site
City
# Site
Dhaka
Niketon
Gazipur Esthema
Dhaka
Gulshan
Dhaka
Bashabo
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
92 95 96
100
104
108
## ## ## ## ## ##
99
203
107
111 ## ## ## c
##
s94
98
102
106
110 ## ## ## ## ##
s93
97
101
105
109 ## ## ## ## ##
Sites: Bangladesh
Site 1= Hatirjheel-Niketon,Dhaka
Site 2= Esthema-Kamarpara,Tongi)
Site 3= Wasa Sewarage Pit-Gulshan,Dhaka
Site 4= Bashabo Sewarage pit,Dhaka
Sample collected fortnightly
22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 #
## ## ## ## ## ## ## ## ##
134 ## ## ## ## ## ## ## ##
133 ## ## ## ## ## ## ## ##
135 ## ## ##
## ## ## ## ##
Summary : : Total site 4
Total sample collected 168
Total sample with result available:
163
Total sample positive for WPV(with type)
0
Total sample positive for VDPV
0
Total sample positive for SLPV3
8
Total sample positive for SLPV2
1
Total sample positive for SLPV1
3
Total sample positive for NPEV
78
Total RD Positive:
90
Total sample NVI:
73
Note: NPML-IPH lab processes: Sewage samples are tested in cell culture, virus isolation done, confirmed by realtime PCR (ITD)
Note: ERC sequencing report has confirmed the ES-158-ITD discordant sample finally as"PV SL3(vaccine) with 2 neucleotide change".
Reported by National Polio Measles and AMES(JE) Laboratory, IPH, Bangladesh
WPV1
VDPV
SLPV2
SL PV3
NPEV
Negetive (NVI)
Discordant
under process
Not collected
SLPV1
Poliovirus Detected in Sewage Samples
Indonesia - 2017
Province
DKI Jakarta
East Java
West Java
Yogyakarta
1
2
3
4
5
6
7
8
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52
Province
1
2
3
4
5
6
7
8
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53
1
2
3
4
5
6
7
8
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52
Thailand -2016
Bangkok
Samut Sakhon
Thailand- 2017
Province
Bangkok
Samut Sakhon
Type 1 Sabin
Type 1 VDPV
Wild polio type 1
Negative for Polio and NPEV
Type 2 Sabin
Type 2 VDPV
Wild polio type 3
Result pending
Type 3 Sabin
Type 3 VDPV
NPEV
Sampling not scheduled
Type 1 Sabin + 3 Sabin
Data as of 06 November 2017
Measles and Rubella Serology (IgM) , 2017
Results
Country
Laboratories
Bangladesh
Dhaka
Bhutan
Thimphu
DPR Korea
India
%
#
%
5592
2395
42.8
188
5.9
64.1
388
388
59
15.2
7
2.1
92.0
67
61
0
0.0
0
0.0
100.0
434
299
68.9
30
22.2
100.0
Bengaluru
688
623
143
23.0
169
35.2
91.5
Bhopal
158
158
111
70.3
4
8.5
99.4
Chandigarh
118
118
38
32.2
11
13.8
100.0
Chennai
832
163
49
30.1
54
47.4
99.4
Delhi
132
132
83
62.9
6
12.2
97.0
Guw ahati
272
153
103
67.3
14
28.0
100.0
80
80
32
40.0
7
14.6
100.0
Jaipur
308
308
208
67.5
7
7.0
79.9
Kolkata
812
812
318
39.2
302
61.1
86.6
1509
1313
763
58.1
84
15.3
84.3
384
384
101
26.3
119
42.0
77.9
Pune
619
462
264
57.1
45
22.7
90.7
6346
5140
2512
48.9
852
32.4
89.0
Bandung
1094
1094
569
52.0
158
30.1
92.7
Jakarta
4407
3263
899
27.6
1012
42.8
29.5
Surabaya
3349
2357
1235
52.4
327
29.1
47.5
India Total
Yogyakarta
Indonesia Total
Maldives
Male
Myanm ar
Yangon
Nepal
Kathmandu
3527
3527
983
27.9
1125
44.2
77.1
12377
10241
3686
36.0
2622
40.0
56.8
87.9
58
58
1
1.7
1
1.8
1493
1483
991
66.8
5
1.0
99.0
709
709
56
7.9
16
2.5
90.4
Colombo
138
137
5
3.6
8
6.1
86.1
Bangkok
548
548
286
52.2
2
0.8
100.0
Chiang Mai
28
28
7
25.0
0
0.0
100.0
Chiang Rai
29
29
7
24.1
0
0.0
86.2
Chon Buri
223
142
48
33.8
1
1.1
100.0
52
52
10
19.2
1
2.4
100.0
7
7
3
42.9
0
0.0
100.0
61
61
27
44.3
2
5.9
100.0
100.0
Khon Kaen
Nakhon Saw an
Nakhonratchasima
Phitsanulok
52
52
15
28.8
2
5.4
Samut Songkhram
383
383
240
62.7
4
2.8
97.9
Songkhla
776
776
631
81.3
3
2.1
100.0
Surat Thani
6
6
0
0.0
0
0.0
100.0
Trang
54
54
10
18.5
8
18.2
100.0
Ubon Ratchathani
54
54
9
16.7
1
2.2
100.0
Udon Thani
11
11
4
36.4
0
0.0
100.0
2284
2203
1297
58.9
24
2.6
99.5
80
80
0
0.0
3
3.8
87.5
29532
26092
11002
42.2
3726
24.7
72.6
Thailand Total
Tim or-Leste
% Measles Results
Reported w ithin 4 Days
Rubella +ve
434
Patna
Thailand
#
5592
Measles +ve
Pyongyang
Lucknow
Sri Lanka
Num ber Tested
Ahmedabad
Hyderabad
Indonesia
Num ber of Serum
Sam ples Received
Dili
TOTAL
Source: Reported by SEAR Measles Laboratory Netw ork
NR=No Report
Source: Monthly Reported by SEAR Measles Laboratory Network
Data as of 30 September 2017